logo
[breadcrumb_custom]

Tag: CTMX Stock

VIPS stock
Stock

CytomX Therapeutics Inc: Weathering Stock Market Storms with 119.19M Market Cap

CytomX Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $2.86 on 03/04/24 and a low of $1.04 for the same time frame on 10/30/23. 52-week price history of CTMX Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. CytomX Therapeutics Inc’s current trading price is -38.35% away from its 52-week high, while its distance from the 52-week low is 69.23%. The stock’s price range during the 52-week period has remained between $1.04 and $2.86. In

Industry

CytomX Therapeutics Inc’s Banking’s 100-Day Moving Average at 1.73: Will the Stock Break Through?

The market performance of CytomX Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $2.86 on 03/04/24, with the lowest value for the same timeframe being $1.04, recorded on 10/30/23. 52-week price history of CTMX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. CytomX Therapeutics Inc’s current trading price is -26.44% away from its 52-week high, while its distance from the 52-week low is 101.92%. The stock’s price range during this period has fluctuated between $1.04 and $2.86. Shares

News

CTMX’s Stochastic Averages Dip: Analyzing CytomX Therapeutics Inc’s Stock Performance

The market performance of CytomX Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $2.86 on 03/04/24, with the lowest value for the same timeframe being $1.04, recorded on 10/30/23. 52-week price history of CTMX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. CytomX Therapeutics Inc’s current trading price is -23.64% away from its 52-week high, while its distance from the 52-week low is 109.62%. The stock’s price range during this period has fluctuated between $1.04 and $2.86. Shares

Stock

A Deep Dive into CytomX Therapeutics Inc (CTMX) Stock Performance

CytomX Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $2.86 on 03/04/24, and the lowest price during the same period was recorded at $1.04 on 10/30/23. 52-week price history of CTMX Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. CytomX Therapeutics Inc’s current trading price is -24.69% away from its 52-week high, while its distance from the 52-week low is 106.73%. The stock’s price range for this period has remained between $1.04

News

CTMX’s Stock Market Puzzle: Piecing Together 2023’s Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 65.16%. However, over the past six months, we’ve seen a weaker performance of 85.51%. The price of CTMX fallen by 75.34% over the last 30 days. And in the last five days, it has surged by 4.49%. CytomX Therapeutics Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $2.86 on 03/04/24, with the lowest value being $1.04

Stock

CytomX Therapeutics Inc (CTMX) Stock: Navigating a Year of Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. CytomX Therapeutics Inc’s current trading price is -12.11% away from its 52-week high, while its distance from the 52-week low is 88.46%. The stock’s price range for this period has been between $1.04 and $2.23 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.18 million for the day, a number notably higher than the average daily volume of 0.32 million over the last three months. CytomX Therapeutics Inc ‘s stock market performance